An advisory panel from the US FDA (Food and drug administration) has advocated for the emergency approval of the Pfizer vaccine for COVID-19. The vaccine was behind in line with the Moderna solution as the latter’s injections were proved to be more effective.
Good news for the Pfizer vaccine for COVID-19!
An advisory panel from FDA voted 17 to 4 for the vaccine to be approved for emergency use on the masses affected by Corona. This committee plays a key role in drug and vaccine approval for the US.
Although FDA does not always have to follow the committee’s reccomendation, it usually does in vaccine approvals.
The approval could be granted as soon as Saturday and it can be distributed to the interested buyers such as India, UK, and China. For the evaluation of safety data, emergency use authorization for vaccines to be administered are usually only allowed on a small group of people.
It is still unclear whether the vaccine will be authorized for certain groups such as children or pregnant women as Pfizer is still running trials for those specific people. The authorization for the distribution of the Pfizer vaccine was only approved for adults or children that are above the age of 16 years.
It is said by the US officials that the vaccine will be distributed within 24 hours of the approval but it will take months to immunize every effectee in the country!
This is it for today’s article! Keep visiting our site for more updates!